Act to End NTDs l West FY2020 Work Plan
USAID's Act to End NTDs | West program will support the elimination of neglected tropical diseases (NTDs) in Benin, Burkina Faso, Cameroon, Ghana, Guinea, Cote d’Ivoire, Mali, Niger, Senegal, Sierra Leone and Togo. The program seeks to build upon the achievements of the END in Africa and ENVISION projects in West Africa in their efforts to eliminate lymphatic filariasis (LF) and trachoma as public health problems, and onchocerciasis (OV) in selected countries. It aims to enable Neglected Tropical Disease programs (NTDPs) to sustain treatment for long-term control programs for schistosomiasis (SCH), soil-transmitted helminths (STH) and OV and to mainstream NTDPs into the national health system.
The Act to End NTDs | West FY2020 Work Plan is built upon the accumulated experience and lessons learned in NTD programs in West Africa and the current program’s first year of implementation, directly by FHI 360 or in collaboration with our partners. These include maximizing the utilization of existing government networks and well-established channels for implementation of NTD activities; partnering with Ministries of Health (MOHs) and other NTD stakeholders to strengthen MOHs and enhance local sustainable capacity in countries; and promoting country ownership in every step of the process.
The FHI 360-led Act | West consortium includes the following partners: Helen Keller International (HKI), Health & Development International (HDI), Deloitte Consulting, World Vision International (WV), AmeriCares, and AIM Initiative.
Type
Work Plan
Year of publication
Disease
All Preventive Chemotherapy NTDs
Country
All Countries, Benin, Burkina Faso, Cameroon, Cote d’Ivoire, Ghana, Guinea, Mali, Niger, Senegal, Sierra Leone, Togo
Focus Areas
Mass Drug Administration (MDA), MDA implementation, Community outreach, Drug procurement & supply chain support, Cross-border initiatives, Annual training for MDA, Support for NTD Sustainability, Advocacy and policies, Cross-sector collaboration, NTD governance, Strategic health information, NTD Capacity Building, Monitoring, Evaluation, Research, Learning and Adapting (MERLA), Disease-specific assessments, post-treatment surveillance, and related training, Disease & morbidity mapping & assessment, Learning & quality improvement, Data for decision-making, Operational research, Dossier development
Partners
AIM Initiative, AmeriCares, Deloitte, FHI360, HDI, Helen Keller International, World Vision